Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar CNBCLilly Reports Q2 2024 Financial Results, Raises Full-Year Revenue Guidance by $3 Billion Investors | Eli Lilly and CompanyEli Lilly raises annual forecasts as weight-loss drug quarterly sales cross $1 billion Yahoo FinanceEli Lilly Lifts 2024 Sales Outlook as Zepbound Demand Drives Quarter BloombergEli Lilly Reports Earnings Thursday Amid a Stock Slump. Here’s What to Expect. Barron’s